Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DECONGEST-AHF
NCT05276219Phase 4Recruiting
- Sponsor
- Rigshospitalet
- Start
- Sep 2023
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Acute Heart Failure (AHF) and pulmonary edema comparing Furosemide only, isosorbide dinitrate and isosorbide dinitrate + furosemide (3 arms). Primary endpoint: Days alive and outside hospital at 30 days. Started Sep 2023; status: recruiting.
02
Drugs
furosemideisosorbide dinitrate
03
Conditions
Acute Heart Failure (AHF)pulmonary edema
Beyond the preview
Go deeper on NCT05276219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05276219.